- Cor Therapeutics Inc.
- Genzyme Drug Discovery & Development
- Enzytech Inc.
- Microbot Medical Inc.
- Merck Serono SA
- Coulter Pharmaceutical Inc.
- Gilead Sciences Inc.
- MedImmune Vaccines
- Affymax NV
- Takeda Oncology
- Myriad Genetics Inc.
- Idera Pharmaceuticals Inc.
- Idec Pharmaceuticals Corp.
- Pharmacyclics Inc.
- Genentech Inc.
- Neurocrine Biosciences Inc.
- Triangle Pharmaceuticals Inc.
- Glaxo Wellcome PLC
- Accelrys Inc.
- GelTex nets $23 million in IPO
- Coulter Pharmaceutical nets $27.2mm in IPO
- Millennium Pharmaceuticals raises $57.75mm in IPO
- Sequana offers 1.7 million shares, nets $30.4 million
- Neurocrine Biosciences raises $34.2mm in IPO of 3.5mm shares.
- Triangle nets $41.1mm in 4.5mm share IPO
- Pharmacopeia's IPO nets $43.8mm
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.